Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03BA02	AERONIDE	G	Budesonide - 400mcg	400mcg	Capsule, inhalation	2,116,552 L.L
A03FA03	PROKININ	G	Domperidone - 10mg	10mg	Tablet, film coated	221,734 L.L
A10BB12	JOSWE GLEMAX 3	G	Glimepiride - 3mg	3mg	Caplet	235,172 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	226,388 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS3	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.60 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l		Injectable solution	L.L
C08CA01	LOWRAC 5	G	Amlodipine (besylate) - 5mg	5mg	Capsule	362,837 L.L
C09DB06	LOSANET AM	G	Losartan potassium - 100mg, Amlodipine - 5mg		Tablet	1,044,358 L.L
G03AD01	EZ-ONE	G	Levonorgestrel - 1.5mg	1.5mg	Tablet	722,987 L.L
H02AB09	HYDROCORTISON VUAB	G	Hydrocortisone hydrogenosuccinate - 100mg	100mg	Injectable dry powder for solution	147,823 L.L
J02AC03	VORICONAZOLE STRAGEN	G	Voriconazole - 50mg	50mg	Tablet, coated	15,808,184 L.L
L01BC07	AZACITIDINE ARROW	G	Azacitidine - 25mg/ml	25mg/ml	Injectable suspension	10,967,854 L.L
N02BE01	PARACETAMOL B.BRAUN	G	Paracetamol - 1000mg/100ml	1000mg/100ml	Injectable solution	129,009 L.L
N05AH03	PREXAL 5	G	Olanzapine - 5mg	5mg	Caplet, film coated	718,956 L.L
N06BA07	MODAFINIL ARROW	G	Modafinil - 100mg	100mg	Tablet	5,361,932 L.L
A10BB12	ORBIDE	G	Glimepiride - 3mg	3mg	Tablet	351,959 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml		Injectable solution	153,990 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS R	G	Potassium chloride - K+:1.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.40 mmol/l, Sodium acetate - Cl-:105.8 mmol/l, Sodium chloride - Na+:140.5 mmol/l		Injectable solution	L.L
C08CA01	LUSTRA	G	Amlodipine - 5mg	5mg	Tablet	485,127 L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 8mg, Amlodipine - 5mg		Capsule, hard	1,376,095 L.L
D04AA32	DERMAMINE ITCH STOPPING	G	Diphenhydramine HCl - 1%, Zinc acetete - 0.1%		Cream	560,382 L.L
G03AD01	PURPLE LINE	G	Levonorgestrel - 1.5mg	1.5mg	Tablet, film coated	1,071,570 L.L
H02AB09	HYDROCORTISONE ORBUCELL	G	Hydrocortisone (sodium succinate) - 100mg	100mg	Injectable powder	1,091,712 L.L
J01DD15	SEFARIN	G	Cefdinir - 125mg/5ml	125mg/5ml	Suspension	1,695,929 L.L
L01BC07	AZACITIDINE EVER PHARMA	G	Azacitidine - 100mg/100ml	25mg/ml	Injectable powder for suspension	10,967,854 L.L
N02BE01	PARACETAMOL MACOPHARMA	G	Paracetamol - 1000mg/100ml	10mg/ml	Injectable solution	9,350,840 L.L
N06BA09	APO-ATOMOXETINE	G	Atomoxetine (HCl) - 60mg	60mg	Capsule	4,731,669 L.L
S01BA07	OPTILONE	G	Fluorometholone - 0.1%	0.1%	Solution	309,084 L.L
A03FA03	DOMIDONE CHAPHA SUGAR FREE	G	Domperidone - 5mg/5ml	5mg/5ml	Suspension	319,963 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	189,262 L.L
B05ZA	CONCENTRATE SOLUTIONFOR HEMODIALYSIS TYPE A	G	Hemodialytics, concentrates -		Injectable solution	L.L

...

189